Cytokinetics | CYTK - Aktuelle Verpflichtungen

Aktienkurs
65.32
Täglich Wechseln
-0.16 -0.24%
Monatlich
4.70%
Jährlich
61.56%
Q2 Prognose
63.92




Aktuelle Verpflichtungen Veränderung Datum
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Amgen USD 25.49B 3.7B 2025-12
Arca Biopharma USD 15.37M 5.59M 2025-12
Bayer EUR 32.58B 3.63B 2025-12
Biogen USD 3.35B 59.4M 2025-12
Brainstorm Cell Therapeutics USD 11.01M 1.98M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Capricor Therapeutics USD 35.84M 7.69M 2025-12
Cytokinetics USD 202.45M 60.31M 2025-12
Eisai JPY 387.67B 9.42B 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Exelixis USD 405.64M 31.86M 2025-12
Geron USD 113.82M 26.11M 2025-12
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
Ligand Pharmaceuticals USD 37.45M 6.91M 2025-12
Merck USD 28.63B 2.59B 2025-09
Novartis USD 27.28B 4.72B 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 30.01B 1.66B 2026-03